Share
4,733 Posts.
lightbulb Created with Sketch. 2170
clock Created with Sketch. 19/02/23
12:44
Share
Originally posted by Steini:
↑
While it is a milestone event for any Bio-tech to start a new trial or move to the next stage of a trial due to the tight trial requirements the general market is only interested in results. " Boring " waiting time, hence the willingness of some to sell out of frustration and impatience which on the other hand opens up fantastic investment opportunities for the patient ones.
Expand
And the NK trial costs us nothing. I am still collecting the crumbs when they fall. This market cap is crazy.
(20min delay)